Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Proof of Concept for a Platform for the Fast and General Elucidation of the Interaction Between Proteins and RNA

Project description

Gaining more insight into the complex relationship between proteins and RNA

RNA-binding proteins (RBPs) are cytoplasmic and nuclear proteins that bind to the single- or double-stranded RNA and participate in forming ribonucleoprotein complexes in cells. Most RBPs in the nucleus exist as complexes of protein and pre-mRNA, called heterogeneous ribonucleoprotein particles. RBPs have crucial roles in various cellular functions, transport and localisation. The EU-funded ProteRNA project is bringing together experts from the academic and non-academic sectors to establish a new platform for the elucidation of the interaction between proteins and RNA. The development of analytical methods for the identification of RPBs and corresponding RNA motifs will create a deeper understanding of the roles of gene regulation and protein expression and also help in the identification of the proteomes involved in specific diseases.

Objective

The aim of this project is to bring together subject matter experts from the academic and non-academic sectors to establish proof-of-concept of the utility of a new platform for fast and general elucidation of the interaction between proteins and RNA. The development of analytical methods for identification of RNA-binding proteins (RPBs) and their corresponding RNA motifs, will permit and accelerate: i) a deeper understanding of the roles of gene regulation and protein expression; ii) development of personalised medicines via regulation of protein expression; and iii) rapid identification of proteomes involved in specific diseases. In doing so, this project will have outputs which have significant market opportunities and societal benefits, including, but not limited to, stimulating job creation in the pharmabiotech and diagnostics sectors and reducing costs for national and EU healthcare budgets.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

MSCA-RISE - Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE)

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-MSCA-RISE-2020

See all projects funded under this call

Coordinator

KELADA PHARMACHEM LIMITED
Net EU contribution
€ 110 400,00
Address
161 RATHMINES ROAD LOWER
A94 Dublin
Ireland
SME
Yes
Region
Ireland Eastern and Midland Dublin
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 110 400,00

Participants (2)